The global heart failure therapeutics market is anticipated to grow at a significant CAGR during the forecast period. Heart failure is a medical condition caused due to abnormal cardiac structure and function. Heart failure is a chronic progressive disorder that affects the blood pumping capacity of the heart muscles, leading to an insufficient supply of blood to the whole body. Heart failure has a significant burden on the global healthcare system, affecting more than 26 million people across the globe. It is estimated that heart failure across the globe had cost around $100 billion in 2012. Among these, the growing global population suffering from cardiovascular illnesses is the primary factor for the increased market growth.
Globally, almost 15 million people suffer from heart attacks or similar issues, according to the World Heart Federation. Six million of these patients will die, while another five million will be severely crippled. In the US, one person dies from CVD every 36 seconds. Heart disease claims the lives of around 659,000 people in the US each year, accounting for one out of every four mortalities. Between 2016 and 2017, the US spent $363 billion on heart disease. This covers the costs of healthcare services, medications, and lost productivity as a result of mortality. The most frequent type of heart illness, coronary heart disease, killed 360,900 people in 2019. These diseases affect approximately 18.2 million persons aged 20 and up (about 6.7%). Adults under the age of 65 account for about 2 out of every 10 mortalities due to coronary artery disease. This results in the rising incidences of heart failure, which in turn, is driving the growth of the global heart failure therapeutics market.
To Request a Sample of our Report on Heart Failure Therapeutics Market: https://www.omrglobal.com/request-sample/heart-failure-therapeutics-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Heart Failure Stage
- By Drug Class
- By Distribution Channel
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Amgen Inc., Johnson & Johnson Services, Inc., and Novartis International AG, among others.
Heart Failure Therapeutics Market Report by Segment
By Heart Failure Stage
- Class I
- Class II
- Class III
- Class IV
By Drug Class
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin Receptor Blockers
- Diuretics
- Beta Blockers
- Procoralan
- Mineralocorticoid Receptor Antagonists
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
A full Report of Heart Failure Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/heart-failure-therapeutics-market
Heart Failure Therapeutics Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
